Zemcelpro® distribution agreement announced for Argentina, Hong Kong and Singapore

PartnershipZemcelproPositive

AI Analysis

Summary

FarmaMondo has been granted distribution rights for Zemcelpro (dorocubicel), a European Commission conditionally authorized cell therapy, in Argentina, Hong Kong, and Singapore.

Outcome Details

Distribution agreement granted for Argentina, Hong Kong and Singapore

Importance:4/10

Sentiment:

0.50

distribution agreementgeographic expansionpartnershipcell therapyhematological malignancies

Read the original article

Published by PR Newswire Biotech on July 16, 2026 11:00 AM

Read Original